Home Applications 040416 Application 040416
Type ANDA
Sponsor UPSHER SMITH LABS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 JANTOVEN WARFARIN SODIUM TABLET;ORAL 1MG No No 002 JANTOVEN WARFARIN SODIUM TABLET;ORAL 2MG No No 003 JANTOVEN WARFARIN SODIUM TABLET;ORAL 2.5MG No No 004 JANTOVEN WARFARIN SODIUM TABLET;ORAL 3MG No No 005 JANTOVEN WARFARIN SODIUM TABLET;ORAL 4MG No No 006 JANTOVEN WARFARIN SODIUM TABLET;ORAL 5MG No No 007 JANTOVEN WARFARIN SODIUM TABLET;ORAL 6MG No No 008 JANTOVEN WARFARIN SODIUM TABLET;ORAL 7.5MG No No 009 JANTOVEN WARFARIN SODIUM TABLET;ORAL 10MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 9 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A040416-001 JANTOVEN WARFARIN SODIUM 1MG TABLET / ORAL AB 2003-10-02 A040416-002 JANTOVEN WARFARIN SODIUM 2MG TABLET / ORAL AB 2003-10-02 A040416-003 JANTOVEN WARFARIN SODIUM 2.5MG TABLET / ORAL AB 2003-10-02 A040416-004 JANTOVEN WARFARIN SODIUM 3MG TABLET / ORAL AB 2003-10-02 A040416-005 JANTOVEN WARFARIN SODIUM 4MG TABLET / ORAL AB 2003-10-02 A040416-006 JANTOVEN WARFARIN SODIUM 5MG TABLET / ORAL AB 2003-10-02 A040416-007 JANTOVEN WARFARIN SODIUM 6MG TABLET / ORAL AB 2003-10-02 A040416-008 JANTOVEN WARFARIN SODIUM 7.5MG TABLET / ORAL AB 2003-10-02 A040416-009 JANTOVEN WARFARIN SODIUM 10MG TABLET / ORAL AB 2003-10-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 9 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 11 · 405 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A040416-001 JANTOVEN 1MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A040416-002 JANTOVEN 2MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A040416-003 JANTOVEN 2.5MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A040416-004 JANTOVEN 3MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A040416-005 JANTOVEN 4MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A040416-006 JANTOVEN 5MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A040416-007 JANTOVEN 6MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A040416-008 JANTOVEN 7.5MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A040416-009 JANTOVEN 10MG TABLET / ORAL AB 2003-10-02 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A040416-001 JANTOVEN 1MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 A040416-002 JANTOVEN 2MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 A040416-003 JANTOVEN 2.5MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 A040416-004 JANTOVEN 3MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 A040416-005 JANTOVEN 4MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 A040416-006 JANTOVEN 5MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 A040416-007 JANTOVEN 6MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 A040416-008 JANTOVEN 7.5MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 A040416-009 JANTOVEN 10MG TABLET / ORAL AB 2003-10-02 c2088c7a36db…2026-09-14 22:38:34 2026-08 A040416-001 JANTOVEN 1MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A040416-002 JANTOVEN 2MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A040416-003 JANTOVEN 2.5MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A040416-004 JANTOVEN 3MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A040416-005 JANTOVEN 4MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A040416-006 JANTOVEN 5MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A040416-007 JANTOVEN 6MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A040416-008 JANTOVEN 7.5MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 A040416-009 JANTOVEN 10MG TABLET / ORAL AB 2003-10-02 84e616aacf4f…2026-08-18 06:07:40 2026-07 A040416-001 JANTOVEN 1MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A040416-002 JANTOVEN 2MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A040416-003 JANTOVEN 2.5MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A040416-004 JANTOVEN 3MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A040416-005 JANTOVEN 4MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A040416-006 JANTOVEN 5MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A040416-007 JANTOVEN 6MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A040416-008 JANTOVEN 7.5MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A040416-009 JANTOVEN 10MG TABLET / ORAL AB 2003-10-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A040416-001 JANTOVEN 1MG TABLET / ORAL AB 2003-10-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A040416-002 JANTOVEN 2MG TABLET / ORAL AB 2003-10-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A040416-003 JANTOVEN 2.5MG TABLET / ORAL AB 2003-10-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A040416-004 JANTOVEN 3MG TABLET / ORAL AB 2003-10-02 011fe1cb6892…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 11 · 405 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 3 of 3 · 42 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 13 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0832-1211 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 0832-1212 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 0832-1213 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 0832-1214 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 0832-1215 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 0832-1216 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 0832-1217 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 0832-1218 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 0832-1219 Jantoven Warfarin Sodium Upsher-Smith Laboratories, LLC ANDA Current 55154-5618 Jantoven Warfarin Sodium Cardinal Health ANDA Current 55154-5619 Jantoven Warfarin Sodium Cardinal Health ANDA Current 55154-5620 Jantoven Warfarin Sodium Cardinal Health ANDA Current 55154-5621 Jantoven Warfarin Sodium Cardinal Health ANDA Current